CVS shares pop 10% on big earnings beat, even as high medical costs drag down insurance unit

Key Points

  • CVS Health reported Q4 revenue and profit that exceeded expectations, despite challenges in its insurance business.
  • The company issued a 2025 earnings outlook in line with Wall Street's expectations but did not provide a revenue forecast.
  • CVS is undergoing a management reshuffle and cost-cutting measures as part of a turnaround plan.
  • The insurance unit, Aetna, faced higher medical costs and lower Medicare Advantage star ratings, impacting profitability.
  • All three business segments of CVS beat Wall Street's expectations for the quarter.

Summary

CVS Health reported a robust fourth-quarter performance, surpassing Wall Street's expectations for both revenue and profit despite ongoing challenges in its insurance segment. The company, under the new leadership of CEO David Joyner, is implementing a turnaround strategy that includes significant cost reductions and a management reshuffle. Despite these efforts, CVS's insurance business, Aetna, experienced an operating loss due to escalating medical costs and lower Medicare Advantage star ratings, which negatively affected the segment's profitability. However, CVS's overall revenue grew by 4.2% year-over-year, driven by increases in its pharmacy and insurance units. The health services segment saw a revenue decline due to the loss of a major client, while the pharmacy and consumer wellness division benefited from higher prescription volumes. CVS's shares rose significantly in premarket trading following the announcement, reflecting investor confidence in the company's strategic direction despite the insurance unit's struggles.

cnbc
February 12, 2025
Stocks
Read article

Related news